Press Releases

Bothell, WA , – FUJIFILM Sonosite, Inc. , the world leader in point-of-care ultrasound (POCUS) solutions, is pleased to announce that Richard Kelly has joined the company as Vice President of R&D. In his new role, Kelly will drive product vision and innovation for FUJIFILM Sonosite, Inc. in the areas of POCUS and ultra-high frequency ultrasound, conceptualising early-stage technology, developing product roadmaps, and leading scientific and engineering advances to identifying profitable product innovations.

"R&D is a critical part of our business and is imperative to the advancement of global health initiatives and outcomes," said Richard Fabian, president and CEO of FUJIFILM Sonosite, Inc. "We are thrilled that Richard is bringing his strong product design and global leadership experience to FUJIFILM Sonosite, Inc., where we never stop pushing the boundaries of technology innovation to advance the future of...

Bothell, WA - FUJIFILM Sonosite, Inc. -- Richard Fabian has been promoted to the role of Chief Executive Officer (CEO) of FUJIFILM Sonosite, Inc., the world leader in point-of-care ultrasound (POCUS) solutions, effective July 1, 2022. Richard joined the company as President and Chief Operating Officer in 2017.

“Richard has demonstrated the ability to lead FUJIFILM Sonosite through challenging times to produce outstanding results,” said General Manager of FUJIFILM Medical Systems Business Division and FUJIFILM Sonosite, Inc., Chairman Masataka Akiyama. “Richard and his leadership group have worked with the entire FUJIFILM Sonosite team to develop and launch two next-generation ultrasound systems over the last three years, breaking sales and production records in the process.”

During his tenure, FUJIFILM Sonosite developed and released two new ultrasound systems, the Sonosite PX in 2020 and the Sonosite LX in 2022. In the midst of a global pandemic, the Sonosite PX...

Clinicians will help investigate the role of point-of-care ultrasound (POCUS) technology in patients with COVID-19.

Bothell, WA — FUJIFILM Sonosite, Inc. , the world leader in point-of-care ultrasound (POCUS) solutions, and the CHEST Foundation , the charitable foundation of the American College of Chest Physicians , announced two recipients of the CHEST Foundation’s Research Grant in Ultrasonography and COVID-19 today. The grants include $30,000 in support and FUJIFILM Sonosite’s newly launched Sonosite PX ultrasound system for the study of POCUS efficacy in diagnosing and treating COVID-19 patients in the intensive care unit (ICU).

As of late- January 2021 , COVID-19 has claimed over 2.1 million lives and infected well over 100 million people across the world. Initial studies report that POCUS’ real-time imaging, mobility and multiple uses provides clinicians with a technology that could be used for the diagnosis, treatment and follow-up care of patients...

Bothell, WA – September 3, 2020 — FUJIFILM Sonosite, Inc. , specialists in developing cutting-edge point-of-care ultrasound (POCUS) solutions, and part of the larger Fujifilm Healthcare portfolio, today announced that the company has received 510(k) Clearance from the U.S. Food & Drug Administration (FDA) for the company’s entire POCUS portfolio to support healthcare providers in performing accurate lung and cardiac imaging in COVID-19 patients.

Fujifilm Sonosite creates point-of-care ultrasound systems and medical informatics solutions along with transducers and accessories that can help physicians improve time-to-diagnosis, patient outcomes, procedural efficiency, and workflow.

“POCUS has emerged as a critical tool to support clinicians in their tireless efforts to evaluate lung and cardiac complications of COVID-19,” said Diku Mandavia, MD, FACEP, FRCPC, Senior Vice President and Chief Medical Officer of FUJIFILM Sonosite, Inc. “We’re very pleased that Fujifilm Sonosite’s POCUS portfolio has received this clearance from the FDA and most...